Total Payments
$37,005
2024 Payments
$7,261
Companies
55
Transactions
1,264
Medicare Patients
9,850
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$24,039 (65.0%)
Other$5,944 (16.1%)
Travel$4,610 (12.5%)
Consulting$2,366 (6.4%)
Education$45.37 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,039 | 1,244 | 65.0% |
| Travel and Lodging | $4,610 | 12 | 12.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,944 | 2 | 10.7% |
| Consulting Fee | $2,366 | 2 | 6.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,000 | 1 | 5.4% |
| Education | $45.37 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $10,774 | 53 | $0 (2021) |
| Amgen Inc. | $6,181 | 120 | $0 (2024) |
| Abbott Laboratories | $3,519 | 92 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,256 | 147 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,968 | 183 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,551 | 116 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,183 | 53 | $0 (2024) |
| Medtronic, Inc. | $1,043 | 73 | $0 (2024) |
| PFIZER INC. | $997.74 | 77 | $0 (2024) |
| Boston Scientific Corporation | $628.81 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,261 | 180 | Amgen Inc. ($4,172) |
| 2023 | $3,436 | 164 | Novartis Pharmaceuticals Corporation ($364.95) |
| 2022 | $2,818 | 170 | Medtronic, Inc. ($404.36) |
| 2021 | $2,989 | 148 | Abbott Laboratories ($432.30) |
| 2020 | $1,652 | 81 | Abbott Laboratories ($376.23) |
| 2019 | $2,258 | 134 | Janssen Pharmaceuticals, Inc ($389.06) |
| 2018 | $3,700 | 176 | Abbott Laboratories ($762.12) |
| 2017 | $12,891 | 211 | BIOTRONIK INC. ($9,757) |
All Payment Transactions
1,264 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2024 | Medtronic, Inc. | SELECTSECURE (Device) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Leads | ||||||
| 12/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/19/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Genetic Disease | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.97 | General |
| Category: Cardiovascular | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.86 | General |
| Category: Cardiovascular | ||||||
| 12/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: LUX-Dx_CRM | ||||||
| 12/10/2024 | Biosense Webster, Inc. | CARTO 3 (Device) | Food and Beverage | In-kind items and services | $38.59 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: Cardiology | ||||||
| 12/06/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/06/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.61 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: Not Applicable | ||||||
| 11/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $31.12 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/07/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $16.13 | General |
| Category: Coronary | ||||||
| 11/05/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: DEVICES | ||||||
| 11/02/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $4.14 | General |
| Category: DEVICES | ||||||
| 11/01/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | AltaThera Pharmaceuticals LLC | Sotalol Hydrochloride (Drug) | Food and Beverage | Cash or cash equivalent | $21.78 | General |
| Category: Cardiovascular | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.29 | General |
| Category: Cardiovascular | ||||||
| 10/31/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.37 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 2,696 | 5,550 | $1.5M | $585,657 |
| 2022 | 40 | 2,551 | 5,120 | $1.3M | $548,896 |
| 2021 | 41 | 2,676 | 4,826 | $1.2M | $545,318 |
| 2020 | 35 | 1,927 | 3,372 | $689,470 | $284,340 |
Total Patients
9,850
Total Services
18,868
Medicare Billing
$2.0M
Procedure Codes
173
All Medicare Procedures & Services
173 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 33285 | Insertion of heart rhythm monitor under skin | Office | 2023 | 24 | 25 | $235,000 | $104,820 | 44.6% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 72 | 73 | $223,500 | $95,116 | 42.6% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 72 | 145 | $145,000 | $59,934 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 285 | 488 | $117,090 | $49,017 | 41.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 151 | 164 | $101,000 | $27,440 | 27.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 157 | 158 | $69,500 | $27,273 | 39.2% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 27 | 28 | $53,910 | $22,582 | 41.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 93 | 734 | $32,965 | $15,180 | 46.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 32 | 301 | $28,735 | $14,018 | 48.8% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 65 | 65 | $33,200 | $13,430 | 40.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 85 | 90 | $38,000 | $13,235 | 34.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 31 | 299 | $26,645 | $12,724 | 47.8% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 72 | 289 | $31,100 | $12,086 | 38.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 145 | 460 | $34,525 | $10,589 | 30.7% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 52 | 468 | $30,260 | $9,740 | 32.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 47 | 95 | $24,350 | $9,692 | 39.8% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 13 | 14 | $30,800 | $9,065 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 56 | $19,940 | $8,137 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 86 | $15,245 | $5,951 | 39.0% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 70 | 85 | $14,950 | $5,908 | 39.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $14,400 | $5,792 | 40.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 297 | 472 | $39,475 | $5,766 | 14.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 80 | 85 | $20,650 | $5,084 | 24.6% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 42 | 137 | $17,045 | $4,083 | 24.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 13 | 14 | $11,100 | $3,378 | 30.4% |
About Dr. Vikram Rajan, M.D
Dr. Vikram Rajan, M.D is a Cardiovascular Disease healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1619186194.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vikram Rajan, M.D has received a total of $37,005 in payments from pharmaceutical and medical device companies, with $7,261 received in 2024. These payments were reported across 1,264 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($24,039).
As a Medicare-enrolled provider, Rajan has provided services to 9,850 Medicare beneficiaries, totaling 18,868 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 173 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology
- Location Santa Monica, CA
- Active Since 05/22/2007
- Last Updated 02/16/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1619186194
Products in Payments
- Repatha (Biological) $5,773
- ELIQUIS (Drug) $2,294
- XARELTO (Drug) $2,256
- MULTAQ (Drug) $980.24
- ENTRESTO (Drug) $913.46
- LEQVIO (Drug) $637.13
- Confirm Rx (Device) $593.82
- Pacemakers (Device) $585.70
- Reveal LINQ (Device) $583.40
- Corlanor (Drug) $407.93
- CARDIVA VASCADE MVP VVCS 6-12F (Device) $397.55
- LifeVest (Device) $396.82
- ICDs (Device) $378.26
- CAMZYOS (Drug) $364.25
- PRALUENT ALIROCUMAB INJECTION (Biological) $361.75
- VERQUVO (Drug) $348.52
- Arcalyst (Drug) $286.91
- NEXLETOL (Drug) $279.04
- VYNDAQEL (Drug) $272.72
- JOT DX (Device) $236.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Santa Monica
Shephal Doshi, M.d, M.D
Cardiovascular Disease — Payments: $2.0M
Cardiovascular Disease $2.0M
Richard Wright, M.d, M.D
Cardiovascular Disease — Payments: $1.8M
Cardiovascular Disease $1.8M
Peter Pelikan, M.d, M.D
Cardiovascular Disease — Payments: $18,000
Cardiovascular Disease $18,000
Dr. George Grifka, M.d, M.D
Cardiovascular Disease — Payments: $12,998
Cardiovascular Disease $12,998
Alexandra Lajoie, M.d, M.D
Cardiovascular Disease — Payments: $9,422
Cardiovascular Disease $9,422
Dr. Christiane Schaeffler, M.d, M.D
Cardiovascular Disease — Payments: $6,604
Cardiovascular Disease $6,604